405 related articles for article (PubMed ID: 18516674)
1. Screening caused rising incidence rates of ductal carcinoma in situ of the breast.
van Steenbergen LN; Voogd AC; Roukema JA; Louwman WJ; Duijm LE; Coebergh JW; van de Poll-Franse LV
Breast Cancer Res Treat; 2009 May; 115(1):181-3. PubMed ID: 18516674
[TBL] [Abstract][Full Text] [Related]
2. [Trends in incidence and treatment of ductal carcinoma in situ of the breast in southeast Netherlands].
Voogd AC; Crommelin MA; Repelaer van Driel OJ; Nolthenius-Puylaert MC; van der Heijden LH; Coebergh JW
Ned Tijdschr Geneeskd; 2000 Apr; 144(14):659-63. PubMed ID: 10774294
[TBL] [Abstract][Full Text] [Related]
3. Incidence of invasive breast cancer and ductal carcinoma in situ in a screening program by age: should older women continue screening?
Erbas B; Amos A; Fletcher A; Kavanagh AM; Gertig DM
Cancer Epidemiol Biomarkers Prev; 2004 Oct; 13(10):1569-73. PubMed ID: 15466971
[TBL] [Abstract][Full Text] [Related]
4. Breast magnetic resonance image screening and ductal lavage in women at high genetic risk for breast carcinoma.
Hartman AR; Daniel BL; Kurian AW; Mills MA; Nowels KW; Dirbas FM; Kingham KE; Chun NM; Herfkens RJ; Ford JM; Plevritis SK
Cancer; 2004 Feb; 100(3):479-89. PubMed ID: 14745863
[TBL] [Abstract][Full Text] [Related]
5. Urban-rural differences in the management of screen-detected invasive breast cancer and ductal carcinoma in situ in victoria.
Kok DL; Chang JH; Erbas B; Fletcher A; Kavanagh AM; Henderson MA; Gertig DM
ANZ J Surg; 2006 Nov; 76(11):996-1001. PubMed ID: 17054549
[TBL] [Abstract][Full Text] [Related]
6. Variations in treatment of ductal carcinoma in situ of the breast: a population-based study in the East Netherlands.
Schouten van der Velden AP; Van Dijck JA; Wobbes T
Eur J Surg Oncol; 2007 May; 33(4):424-9. PubMed ID: 17084060
[TBL] [Abstract][Full Text] [Related]
7. Detection method and breast carcinoma histology.
Newcomer LM; Newcomb PA; Trentham-Dietz A; Storer BE; Yasui Y; Daling JR; Potter JD
Cancer; 2002 Aug; 95(3):470-7. PubMed ID: 12209738
[TBL] [Abstract][Full Text] [Related]
8. [Nationwide breast cancer screening fully accomplished; results from the implementation phase 1990-1997. National Evaluation Team for Breast Cancer Screening].
Ned Tijdschr Geneeskd; 2000 Jun; 144(23):1124-9. PubMed ID: 10876708
[TBL] [Abstract][Full Text] [Related]
9. MRI screening in a clinic population with a family history of breast cancer.
Yu J; Park A; Morris E; Liberman L; Borgen PI; King TA
Ann Surg Oncol; 2008 Feb; 15(2):452-61. PubMed ID: 18026801
[TBL] [Abstract][Full Text] [Related]
10. [Contributions of the epidemiological cancer registries to the evaluation of mammography screening in Germany].
Urbschat I; Kieschke J; Schlanstedt-Jahn U; von Gehlen S; Thiel A; Jensch P
Gesundheitswesen; 2005 Jul; 67(7):448-54. PubMed ID: 16103967
[TBL] [Abstract][Full Text] [Related]
11. Results of 23,810 cases of ductal carcinoma-in-situ.
Sumner WE; Koniaris LG; Snell SE; Spector S; Powell J; Avisar E; Moffat F; Livingstone AS; Franceschi D
Ann Surg Oncol; 2007 May; 14(5):1638-43. PubMed ID: 17245612
[TBL] [Abstract][Full Text] [Related]
12. Age-specific incidence rates of in situ breast carcinomas by histologic type, 1980 to 2001.
Li CI; Daling JR; Malone KE
Cancer Epidemiol Biomarkers Prev; 2005 Apr; 14(4):1008-11. PubMed ID: 15824180
[TBL] [Abstract][Full Text] [Related]
13. Predictors of surgical margin status in breast-conserving surgery within a breast screening program.
Kurniawan ED; Wong MH; Windle I; Rose A; Mou A; Buchanan M; Collins JP; Miller JA; Gruen RL; Mann GB
Ann Surg Oncol; 2008 Sep; 15(9):2542-9. PubMed ID: 18618180
[TBL] [Abstract][Full Text] [Related]
14. Hormone replacement therapy, mammography screening and changing age-specific incidence rates of breast cancer: an ecological study comparing two European populations.
Verkooijen HM; Koot VC; Fioretta G; van der Heiden M; Schipper ME; Rapiti E; Peeters PH; Peterse JL; Bouchardy C
Breast Cancer Res Treat; 2008 Feb; 107(3):389-95. PubMed ID: 17431760
[TBL] [Abstract][Full Text] [Related]
15. Modelling the impact of detecting and treating ductal carcinoma in situ in a breast screening programme.
McCann J; Treasure P; Duffy S
J Med Screen; 2004; 11(3):117-25. PubMed ID: 15333269
[TBL] [Abstract][Full Text] [Related]
16. Balancing sensitivity and specificity: sixteen year's of experience from the mammography screening programme in Copenhagen, Denmark.
Utzon-Frank N; Vejborg I; von Euler-Chelpin M; Lynge E
Cancer Epidemiol; 2011 Oct; 35(5):393-8. PubMed ID: 21239242
[TBL] [Abstract][Full Text] [Related]
17. On the rising trends of incidence and prognosis for breast cancer patients diagnosed 1975-2004: a long-term population-based study in southeastern Netherlands.
Louwman WJ; Voogd AC; van Dijck JA; Nieuwenhuijzen GA; Ribot J; Pruijt JF; Coebergh JW
Cancer Causes Control; 2008 Feb; 19(1):97-106. PubMed ID: 18038250
[TBL] [Abstract][Full Text] [Related]
18. Trends in detection of invasive cancer and ductal carcinoma in situ at biennial screening mammography in Spain: a retrospective cohort study.
Román M; Rué M; Sala M; Ascunce N; Baré M; Baroja A; De la Vega M; Galcerán J; Natal C; Salas D; Sánchez-Jacob M; Zubizarreta R; Castells X;
PLoS One; 2013; 8(12):e83121. PubMed ID: 24376649
[TBL] [Abstract][Full Text] [Related]
19. Incidence of and treatment for ductal carcinoma in situ of the breast.
Ernster VL; Barclay J; Kerlikowske K; Grady D; Henderson C
JAMA; 1996 Mar; 275(12):913-8. PubMed ID: 8598618
[TBL] [Abstract][Full Text] [Related]
20. Evolution of breast cancer screening in countries with intermediate and increasing incidence of breast cancer.
Wu GH; Chen LS; Chang KJ; Hou MF; Chen SC; Liu TJ; Huang CS; Hsu GC; Yu CC; Jeng LL; Chen ST; Chou YH; Wu CY; Shin-Lan K; Chen TH;
J Med Screen; 2006; 13 Suppl 1():S23-7. PubMed ID: 17227638
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
